Cannabidiol (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cannabidiol" in Catalan language version.

refsWebsite

Global rank Catalan rank

31nih.gov

4^th place

7^th place

27doi.org

2^nd place

6^th place

6web.archive.org

1^st place

4worldcat.org

5^th place

3fda.gov

447^th place

656^th place

2europa.eu

68^th place

49^th place

1figshare.com

5,893^rd place

low place

1harvard.edu

18^th place

40^th place

1sciencenews.org

3,410^th place

2,654^th place

1nihr.ac.uk

low place

1sciencebasedmedicine.org

5,063^rd place

low place

1frontiersin.org

4,679^th place

1,548^th place

doi.org

dx.doi.org

«Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 367, 1607, 12-2012, pàg. 3364–3378. DOI: 10.1098/rstb.2011.0389. PMC: 3481531. PMID: 23108553.
«A scoping review of the use of cannabidiol in psychiatric disorders». Psychiatry Research, vol. 308, 2-2022, pàg. 114347. DOI: 10.1016/j.psychres.2021.114347. PMC: 8799523. PMID: 34952255.
«Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis». The Lancet. Psychiatry, vol. 6, 12, 12-2019, pàg. 995–1010. DOI: 10.1016/S2215-0366(19)30401-8. PMC: 6949116. PMID: 31672337.
«Clinicians' Guide to Cannabidiol and Hemp Oils». Mayo Clinic Proceedings, vol. 94, 9, 9-2019, pàg. 1840–1851. DOI: 10.1016/j.mayocp.2019.01.003. PMID: 31447137.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, 1-2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol». International Journal of Pharmaceutics, vol. 581, 5-2020, pàg. 119276. DOI: 10.1016/j.ijpharm.2020.119276. PMID: 32243971.
«A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states». Expert Opinion on Drug Delivery, vol. 16, 10, 10-2019, pàg. 1031–1035. DOI: 10.1080/17425247.2019.1653852. PMID: 31393180.
«Cannabidiol: State of the art and new challenges for therapeutic applications». Pharmacology & Therapeutics, vol. 175, 7-2017, pàg. 133–150. DOI: 10.1016/j.pharmthera.2017.02.041. PMID: 28232276.
«A systematic review of the antipsychotic properties of cannabidiol in humans». Schizophrenia Research, vol. 162, 1–3, 3-2015, pàg. 153–161. DOI: 10.1016/j.schres.2015.01.033. PMID: 25667194.
«Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ⁹-Tetrahydrocannabinol». Neuropsychopharmacology, vol. 43, 1, 1-2018, pàg. 142–154. DOI: 10.1038/npp.2017.209. PMC: 5719112. PMID: 28875990.
«Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes». Journal of Natural Products, vol. 79, 2, 2-2016, pàg. 324–331. DOI: 10.1021/acs.jnatprod.5b00949. PMID: 26836472.
«CBD, a precursor of THC in e-cigarettes». Scientific Reports, vol. 11, 1, 4-2021, pàg. 8951. Bibcode: 2021NatSR..11.8951C. DOI: 10.1038/s41598-021-88389-z. PMC: 8076212. PMID: 33903673.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, 2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review». European Archives of Psychiatry and Clinical Neuroscience, vol. 269, 1, 2-2019, pàg. 87–105. DOI: 10.1007/s00406-019-00984-4. PMC: 6595000. PMID: 30706168.
«Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence». Journal of Neurology, Neurosurgery, and Psychiatry, vol. 89, 7, 7-2018, pàg. 741–753. DOI: 10.1136/jnnp-2017-317168. PMID: 29511052.
«Cannabis-based products for pediatric epilepsy: An updated systematic review». Seizure, vol. 75, 2-2020, pàg. 18–22. DOI: 10.1016/j.seizure.2019.12.006. PMID: 31865133.
«Cannabis derivative may reduce seizures in some severe drug-resistant epilepsies, but adverse events increase». NIHR Evidence, 26-06-2018. DOI: 10.3310/signal-000606.
«Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders». Epilepsia, vol. 55, 6, 6-2014, pàg. 791–802. DOI: 10.1111/epi.12631. PMC: 4707667. PMID: 24854329.
«Cannabidiol as a Potential Treatment for Anxiety Disorders». Neurotherapeutics, vol. 12, 4, 10-2015, pàg. 825–836. DOI: 10.1007/s13311-015-0387-1. PMC: 4604171. PMID: 26341731.
«Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review». Cureus, vol. 14, 7, 7-2022, pàg. e26913. DOI: 10.7759/cureus.26913. PMC: 9288157. PMID: 35860716.
«Safety and Toxicology of Cannabinoids». Neurotherapeutics, vol. 12, 4, 10-2015, pàg. 735–746. DOI: 10.1007/s13311-015-0380-8. PMC: 4604177. PMID: 26269228.
«Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb». Trends in Pharmacological Sciences, vol. 30, 10, 10-2009, pàg. 515–527. DOI: 10.1016/j.tips.2009.07.006. PMID: 19729208.
Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 9-2014, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 6-2018, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.
Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.
«The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease». International Journal of Molecular Sciences, vol. 21, 18, 9-2020, pàg. 6740. DOI: 10.3390/ijms21186740. PMC: 7554803. PMID: 32937917.

europa.eu

ema.europa.eu

«Epidyolex EPAR». European Medicines Agency (EMA), 24-06-2019. Arxivat de l'original el August 9, 2021. [Consulta: 11 setembre 2020]. Text was copied from this source which is copyrighted by the European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

ec.europa.eu

«CosIng - Cosmetics - GROWTH - European Commission». [Consulta: 1r març 2023].

fda.gov

Office of the Commissioner. «FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease» (en anglès). FDA, 31-07-2020. Arxivat de l'original el September 29, 2021. [Consulta: 25 novembre 2020].
Office of the Commissioner. «FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy» (en anglès). FDA, 27-03-2020. Arxivat de l'original el April 23, 2019. [Consulta: 28 maig 2021].
«What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding». US Food and Drug Administration (FDA), 16-10-2019. Arxivat de l'original el October 17, 2019. [Consulta: 17 octubre 2019].

figshare.com

«Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes». Journal of Natural Products, vol. 79, 2, 2-2016, pàg. 324–331. DOI: 10.1021/acs.jnatprod.5b00949. PMID: 26836472.

frontiersin.org

Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.

harvard.edu

adsabs.harvard.edu

«CBD, a precursor of THC in e-cigarettes». Scientific Reports, vol. 11, 1, 4-2021, pàg. 8951. Bibcode: 2021NatSR..11.8951C. DOI: 10.1038/s41598-021-88389-z. PMC: 8076212. PMID: 33903673.

nih.gov

ncbi.nlm.nih.gov

«Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 367, 1607, 12-2012, pàg. 3364–3378. DOI: 10.1098/rstb.2011.0389. PMC: 3481531. PMID: 23108553.
«A scoping review of the use of cannabidiol in psychiatric disorders». Psychiatry Research, vol. 308, 2-2022, pàg. 114347. DOI: 10.1016/j.psychres.2021.114347. PMC: 8799523. PMID: 34952255.
«Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis». The Lancet. Psychiatry, vol. 6, 12, 12-2019, pàg. 995–1010. DOI: 10.1016/S2215-0366(19)30401-8. PMC: 6949116. PMID: 31672337.
«Clinicians' Guide to Cannabidiol and Hemp Oils». Mayo Clinic Proceedings, vol. 94, 9, 9-2019, pàg. 1840–1851. DOI: 10.1016/j.mayocp.2019.01.003. PMID: 31447137.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, 1-2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol». International Journal of Pharmaceutics, vol. 581, 5-2020, pàg. 119276. DOI: 10.1016/j.ijpharm.2020.119276. PMID: 32243971.
«A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states». Expert Opinion on Drug Delivery, vol. 16, 10, 10-2019, pàg. 1031–1035. DOI: 10.1080/17425247.2019.1653852. PMID: 31393180.
«Cannabidiol: State of the art and new challenges for therapeutic applications». Pharmacology & Therapeutics, vol. 175, 7-2017, pàg. 133–150. DOI: 10.1016/j.pharmthera.2017.02.041. PMID: 28232276.
«A systematic review of the antipsychotic properties of cannabidiol in humans». Schizophrenia Research, vol. 162, 1–3, 3-2015, pàg. 153–161. DOI: 10.1016/j.schres.2015.01.033. PMID: 25667194.
«Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ⁹-Tetrahydrocannabinol». Neuropsychopharmacology, vol. 43, 1, 1-2018, pàg. 142–154. DOI: 10.1038/npp.2017.209. PMC: 5719112. PMID: 28875990.
«Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes». Journal of Natural Products, vol. 79, 2, 2-2016, pàg. 324–331. DOI: 10.1021/acs.jnatprod.5b00949. PMID: 26836472.
«CBD, a precursor of THC in e-cigarettes». Scientific Reports, vol. 11, 1, 4-2021, pàg. 8951. Bibcode: 2021NatSR..11.8951C. DOI: 10.1038/s41598-021-88389-z. PMC: 8076212. PMID: 33903673.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, 2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review». European Archives of Psychiatry and Clinical Neuroscience, vol. 269, 1, 2-2019, pàg. 87–105. DOI: 10.1007/s00406-019-00984-4. PMC: 6595000. PMID: 30706168.
«Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence». Journal of Neurology, Neurosurgery, and Psychiatry, vol. 89, 7, 7-2018, pàg. 741–753. DOI: 10.1136/jnnp-2017-317168. PMID: 29511052.
«Cannabis-based products for pediatric epilepsy: An updated systematic review». Seizure, vol. 75, 2-2020, pàg. 18–22. DOI: 10.1016/j.seizure.2019.12.006. PMID: 31865133.
«Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders». Epilepsia, vol. 55, 6, 6-2014, pàg. 791–802. DOI: 10.1111/epi.12631. PMC: 4707667. PMID: 24854329.
«The relationship between cannabidiol and psychosis: A review». Annals of Clinical Psychiatry, vol. 27, 2, 5-2015, pàg. 134–141. PMID: 25954940.
«Cannabidiol as a Potential Treatment for Anxiety Disorders». Neurotherapeutics, vol. 12, 4, 10-2015, pàg. 825–836. DOI: 10.1007/s13311-015-0387-1. PMC: 4604171. PMID: 26341731.
«Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review». Cureus, vol. 14, 7, 7-2022, pàg. e26913. DOI: 10.7759/cureus.26913. PMC: 9288157. PMID: 35860716.
«Safety and Toxicology of Cannabinoids». Neurotherapeutics, vol. 12, 4, 10-2015, pàg. 735–746. DOI: 10.1007/s13311-015-0380-8. PMC: 4604177. PMID: 26269228.
«Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb». Trends in Pharmacological Sciences, vol. 30, 10, 10-2009, pàg. 515–527. DOI: 10.1016/j.tips.2009.07.006. PMID: 19729208.
Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 9-2014, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 6-2018, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.
Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.
«The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease». International Journal of Molecular Sciences, vol. 21, 18, 9-2020, pàg. 6740. DOI: 10.3390/ijms21186740. PMC: 7554803. PMID: 32937917.

pubmed.ncbi.nlm.nih.gov

Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 9-2014, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 6-2018, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.

dailymed.nlm.nih.gov

«Epidiolex – cannabidiol solution». DailyMed, 26-08-2020. Arxivat de l'original el February 25, 2021. [Consulta: 11 setembre 2020].

nihr.ac.uk

evidence.nihr.ac.uk

«Cannabis derivative may reduce seizures in some severe drug-resistant epilepsies, but adverse events increase». NIHR Evidence, 26-06-2018. DOI: 10.3310/signal-000606.

sciencebasedmedicine.org

«Where Are We With CBD?». Science-Based Medicine, 30-09-2020. Arxivat de l'original el August 12, 2021. [Consulta: 1r octubre 2020].

sciencenews.org

«The CBD boom is way ahead of the science». Science News, 27-03-2019.

web.archive.org

«Epidiolex – cannabidiol solution». DailyMed, 26-08-2020. Arxivat de l'original el February 25, 2021. [Consulta: 11 setembre 2020].
Office of the Commissioner. «FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease» (en anglès). FDA, 31-07-2020. Arxivat de l'original el September 29, 2021. [Consulta: 25 novembre 2020].
«Epidyolex EPAR». European Medicines Agency (EMA), 24-06-2019. Arxivat de l'original el August 9, 2021. [Consulta: 11 setembre 2020]. Text was copied from this source which is copyrighted by the European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
Office of the Commissioner. «FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy» (en anglès). FDA, 27-03-2020. Arxivat de l'original el April 23, 2019. [Consulta: 28 maig 2021].
«Where Are We With CBD?». Science-Based Medicine, 30-09-2020. Arxivat de l'original el August 12, 2021. [Consulta: 1r octubre 2020].
«What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding». US Food and Drug Administration (FDA), 16-10-2019. Arxivat de l'original el October 17, 2019. [Consulta: 17 octubre 2019].

worldcat.org

Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 9-2014, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 6-2018, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.
Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.